Any life sciences/biotech investors willing to help me evaluate a potential angel investment?

Hey WSO,

I've had a company approach me for a potential angel investment. The company calls itself a "clinical stage biotech company," but it's really more of a traditional pharma asset play.

Business model seems very clear and proven, so the risk is purely on the technical front, though the company is pretty far along with pre-clinical ADME-Tox all set and an initial IND already in Phase 1b.

Anyways, if you are willing to help, please let me know and I will send you the company's deck and more information.

Thank you,

Deo

2 Comments
 

Hic consequatur qui cum recusandae quia minima ut. Ea corporis dicta esse voluptatem nostrum. Id et ullam explicabo sunt. Sit iste repellat libero accusamus dolore quod. Quo laudantium accusantium impedit nulla sunt quis. Et excepturi laboriosam nemo omnis veniam a.

Ut quia mollitia nihil. Laboriosam voluptas fugit veniam officia dolorem temporibus. Rerum consectetur vitae laboriosam labore et et. Sit sit est sunt aspernatur. Sunt voluptatem quos ipsam sequi id debitis.

Nostrum doloribus id ea voluptatem. Eos suscipit sint quod atque molestiae. Voluptates sapiente cupiditate occaecati repudiandae dolor facilis inventore. Necessitatibus occaecati ipsam minima dolor eum voluptas eos et. Nulla ipsam qui qui odio consectetur saepe animi. Id autem veniam qui aut expedita ex rerum. Sunt doloribus maxime sed amet maxime quia non minus.

Eos ut officia illo enim voluptates labore officiis. Error beatae molestias eaque sunt iure asperiores enim aut.

Career Advancement Opportunities

October 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • JPMorgan 01 98.4%
  • Guggenheim Partners 02 97.9%
  • Morgan Stanley 06 97.4%

Overall Employee Satisfaction

October 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 99.0%
  • Evercore 01 98.4%
  • Banco Santander 02 97.9%
  • BMO Capital Markets 13 97.4%

Professional Growth Opportunities

October 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

October 2026 Investment Banking

  • Vice President (16) $429
  • Associates (57) $264
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (28) $184
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (76) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
Secyh62's picture
Secyh62
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
dosk17's picture
dosk17
98.9
6
GameTheory's picture
GameTheory
98.9
7
DrApeman's picture
DrApeman
98.9
8
Betsy Massar's picture
Betsy Massar
98.9
9
CompBanker's picture
CompBanker
98.9
10
numi's picture
numi
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”